UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Inc ...

Milestone Scientific, Inc. (NYSE:MLSS) Q1 2020 Results Earnings Conference Call May 18, 2020 8:00 AM ET Company Participants David Waldman - IR, Crescendo Communications, LLC Leonard Osser - Interim Chief Executive Officer, Director of China Operations Joseph D'Agostino - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Greetings and welcome to the Milestone Scientific First Quarter 2020 Business Update Conference Call. At this time, all participants are in a list ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2020 Or Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdictio ...

Milestone Scientific Inc. (NYSE:MLSS) Q3 2019 Results Conference Call November 15, 2019 8:30 AM ET Company Participants David Waldman - IR Len Osser - Interim CEO Joseph D'Agostino - CFO Conference Call Participants Anthony Vendetti - Maxim Operator Good day and welcome to the Milestone Scientific Incorporated Third Quarter 2019 Investor Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. David Waldman, Investor Relations. Please go ahead, sir. David Wal ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) State or other jurisdiction of Incorporation o ...

Milestone Scientific, Inc. (NYSE:MLSS) Q2 2019 Results Conference Call August 16, 2019 8:30 AM ET Company Participants Natalya Rudman - Investor Relations Leonard Osser - Interim Chief Executive Officer Joseph D'Agostino - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Tony Kamin - Eastwood Partners Operator Good day and welcome to the Milestone Scientific Second Quarter 2019 Investor Call. Today's conference is being recorded. At this time, I would like to turn the conf ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of ...

Milestone Scientific Inc (NYSE:MLSS) Q4 2018 Earnings Conference Call April 3, 2019 8:30 AM ET Company Participants David Waldman - Investor Relations Leonard Osser - Interim Chief Executive Officer Joseph D???Agostino - Chief Financial Officer and Chief Operating Officer Conference Call Participants Alexander Scharf - Maxim Group Anthony Marchese - Private Investor Les Collins - Private Investor Tony Kamin - Eastwood Partners Ricky Solomon - Private Investor Operator Good day and welcome to the Milestone S ...